Abstract
Cancer is a disease of uncontrolled cell growth. Cancer cells grow abnormally because of damage to their DNA. This DNA damage garbles the genetic signals for normal growth. The molecular approach to cancer gets to the heart of the matter. Molecular studies have uncovered many of the details whereby a normal cell becomes cancerous. These discoveries have revealed cancer to be a multistep process, involving the progressive loss of control by the malignant cell, failure of DNA repair, and of loss of backup systems for preventing abnormal cell growth. We have discovered oncogenes, which promote tumor growth, as well as anti-oncogenes, which suppress tumors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Ayscue LH, Ross DW, Ozer H, Rao K, Gulley ML, Dent GA (1990) Bcr/abl recombinant DNA analysis versus karyotype in the diagnosis and therapeutic monitoring of chronic myeloid leukemia. Am J Clin Pathol 94: 404–409.
Bayever E, Iversen P (1994) Oligonucleotides in the treatment of leukemia. Hematol Oncol 12: 9–14.
Burkitt D, O’Conor GT (1961) Malignant lymphoma in African children I. A clinical syndrome. Cancer 14: 258–269.
Cole HM (ed) (1993) Diagnostic and therapeutic technology assessment: human papillomavirus DNA testing in the management of cervical neoplasia. JAMA 270: 2975–2981.
Cossman J (ed) (1990) Molecular Genetics in Cancer Diagnosis. Elsevier, NY.
Cossman J, Zehnbauer B, Garrett CT, Smith LJ, Williams M, Jaffe ES, Hanson LO, Love J (1991) Gene rearrangements in the diagnosis of lymphoma/leukemia. Am J Clin Pathol 95: 347–354.
Daley GQ, van Etten RA, Baltimore D (1990) Induction of chronic myelogenous leukemia in mice by the p210bcr/abl gene of the Philadelphia chromosome. Science 247: 824–830.
de The H, Chomienne C, Lanotte M, Degos L, Dejean A (1990) The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347: 558–561.
Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 6 (61): 759–767.
Gulley ML, Dent GA, Ross DW (1992) Classification and staging of lymphoma by molecular genetics. Cancer (Suppl) 69: 1600–1606.
Hamilton SR (1992) Molecular genetics of colorectal carcinoma. Cancer 70: 1216–1221.
Harris CC, Hollstein M (1993) Clinical implications of the p53 tumor suppressor gene. N Engl J Med 329: 1318–1327.
Heisterkamp N, Stam K, Groffen J, de Klein A, Grosveld G (1985) Structural organization of the bcr gene and its role in the Ph’ translocation. Nature 315: 758–761.
Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ (1990) Bc1–2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334–336.
Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253: 49–53.
Huang ME, Ye YI, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY (1988) Use of all trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567–571.
Jacquemier J, Penault F, Durst M, Parc P, Seradour B, Meynard P, Halfon P, Hassoun J (1990) Detection of five different human papillomavirus types in cervical lesions by in situ hybridization. Hum Pathol 21: 911–917.
Jen J, Kim H, Piantadosi S, et al. (1994) Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331: 213–221.
Kern SE, Fearon ER, Tersmette KWF, Enterline JP, Leppert M, Nakamura Y, White R, Vogelstein B, Hamilton S (1989) Allelic loss in colorectal carcinoma. JAMA 261 (21): 3099–3103.
Lane DP (1994) p53 and human cancers. Br Med Bull 50:582–599.
Longo L, Pandolfi PP, Biondi A, Rambaldi A, Mencarelli A, Lo Coco F, Diverio D, Pegoraro L, Avanzi G, Tabilio A, Zangrilli D, Alcalay M, Donti E, Grignani F, Pelicci PG (1990) Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias. J Exp Med 172: 1571–1575.
Lyons J, private communication; see also Lyons J, Landis CA, Harsh G, et al. (1990) Two G protein oncogenes in human endocrine tumors. Science 249: 655–659.
McDonnell TJ, Korsmeyer SJ (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349: 254–256.
National Advisory Council for Human Genome Research (1994) Statement on use of DNA testing for presymptomatic identification of cancer risk. JAMA 271: 785.
Ross DW, Brunning RD, Kantarjian HM, Koeffler HP, Ozer H (1993) A proposed staging system for chronic myeloid leukemia, Cancer 71: 3788–3791.
Shattuck-Eidens D, McClure H, Simard J, et al. (1995) A collaborative survey of 80 mutations in the brcal breast and ovarian cancer susceptibility gene. JAMA 273: 535–541.
Slamon DJ, Godolphin W, Jones LA, et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707–712.
Stanbridge EF, Nowell PC (1990) Origins of human cancer revisited. Cell 63: 867–874.
zur Hausen H (1987) Papillomaviruses in human cancer. Cancer 59: 1692–1696.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ross, D.W. (1996). Cancer. In: Introduction to Molecular Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2460-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2460-8_8
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-94468-5
Online ISBN: 978-1-4757-2460-8
eBook Packages: Springer Book Archive